Greater Baltimore Medical Center (GBMC)

Baltimore, Maryland 21204

We've found

1 trials

at this facility

A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!